儿童脓毒症或严重感染性休克液体推注后死亡率:系统评价与Meta分析
该系统评价与Meta分析检索截至2020年3月30日的文献,纳入19项研究共9321例儿童严重脓毒症或脓毒症休克患者。17项报告48小时死亡率的研究显示,无推注组较推注组死亡率降低(RR 0.74,95%CI 0.62-0.88,P<0.01,I²=0%)。疟疾休克患者中胶体与晶体液结果相似(RR 0.79,95%CI 0.62-1.02)。一般休克亚组无显著差异(RR 0.79,95%CI 0.62-1.02,P=0.07)。2项研究报告第4周死亡率,无推注组较推注组降低(RR 0.71,95%CI 0.57-0.88,I²=0%)。作者认为需长期随访和更大样本的Meta分析来验证结论。
要点
- 17项研究报告48小时死亡率:无推注组较推注组降低(RR 0.74,95%CI 0.62-0.88,P<0.01,I²=0%)。
- 疟疾休克患者中胶体与晶体液比较:RR 0.79(95%CI 0.62-1.02)。
- 一般休克亚组无推注组与推注组无显著差异(RR 0.79,95%CI 0.62-1.02,P=0.07,I²=0%)。
- 2项研究报告第4周死亡率,无推注组较推注组降低(RR 0.71,95%CI 0.57-0.88,I²=0%)。
- 作者认为需长期随访和更大样本的Meta分析来验证结论。
适用人群与场景
- 儿童严重脓毒症或脓毒症休克患者,共9321例,来自19项研究。
研究设计与关键结果
- 系统评价与Meta分析,纳入19项研究共9321例儿童严重脓毒症或脓毒症休克患者,质量可接受。
- 17项报告48小时死亡率的研究:无推注组较推注组死亡率降低(RR 0.74,95%CI 0.62-0.88,P<0.01,I²=0%)。
- 疟疾休克患者中胶体与晶体液比较:RR 0.79(95%CI 0.62-1.02)。
- 一般休克亚组:无推注组与推注组无显著差异(RR 0.79,95%CI 0.62-1.02,P=0.07,I²=0%)。
- 2项研究报告第4周死亡率:无推注组较推注组降低(RR 0.71,95%CI 0.57-0.88,I²=0%)。
证据类型、等级与局限
- 系统评价与Meta分析,检索PubMed、MEDLINE、Cochrane Library和EMBASE截至2020年3月30日。
- 局限:作者认为需长期随访和更大样本的Meta分析来验证结论。
对床旁实践的改变
- 作者认为在儿童严重脓毒症或感染性休克中,无液体推注策略在48小时死亡率方面优于液体推注策略,尤其在疟疾休克患者中。
- 作者认为需长期随访和更大样本的Meta分析来验证结论。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: A considerable debate on whether fluid bolus could decrease childhood mortality in pediatric patients with septic or severe infection shock is still unresolved. A systematic review and meta-analysis was conducted to investigate the mortality rates after fluid bolus among children with septic or severe infection shock.
METHODS: A systematic electronic search of PubMed, MEDLINE, Cochrane Library, and EMBASE databases was conducted to identify relevant published studies till March 30, 2020.
RESULTS: A total of 19 studies with 9,321 severe sepsis or septic shock pediatric patients were included and exhibited an acceptable quality. Of the 17 studies that reported mortality at 48 h, no bolus group decreased the mortality rate when compared with bolus group with a risk ratio (RR) of 0.74 [95% confidence interval (CI) = 0.62-0.88, P < 0.01], and showed no heterogeneity (I2 = 0%). Similar results were observed on colloids and crystalloids solution in malaria shock cases with a RR of 0.79 (95% CI = 0.62-1.02). For the subgroup of general shock patients, no significant difference was shown with an RR of 0.79 (95% CI = 0.62-1.02, P = 0.07) and no significant heterogeneity (I2 = 0%). Two studies reported mortality at week 4 and pooled results indicated that no bolus group was protective against mortality when compared with bolus group with RR of 0.71 (95% CI = 0.57-0.88, I2 = 0%).
CONCLUSION: For the mortality at 48 h, the no bolus group showed decreased mortality when compared with the bolus group, especially in the malaria group. Similar results were found in the colloids and crystalloids solution in patients with malaria shock. Meta-analysis studies with long-term follow-up period and larger sample size are warranted to address the conclusion in the future.
参考来源
- Yue J, Zheng R, Wei H, et al. Childhood Mortality After Fluid Bolus With Septic or Severe Infection Shock: A Systematic Review and Meta-Analysis. Shock. 2021. PMID: 32881758. doi:10.1097/SHK.0000000000001657
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。